433 related articles for article (PubMed ID: 17631184)
1. Hematopoietic growth factors including keratinocyte growth factor in allogeneic and autologous stem cell transplantation.
Seggewiss R; Einsele H
Semin Hematol; 2007 Jul; 44(3):203-11. PubMed ID: 17631184
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
3. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic growth factors for hematopoietic stem cell mobilization and expansion.
Möhle R; Kanz L
Semin Hematol; 2007 Jul; 44(3):193-202. PubMed ID: 17631183
[TBL] [Abstract][Full Text] [Related]
5. The effect of hematopoietic growth factors on the risk of graft-vs-host disease after allogeneic hematopoietic stem cell transplantation: a meta-analysis.
Ho VT; Mirza NQ; Junco Dd Dd; Okamura T; Przepiorka D
Bone Marrow Transplant; 2003 Oct; 32(8):771-5. PubMed ID: 14520420
[TBL] [Abstract][Full Text] [Related]
6. [Immune reconstitution and regulation following autologous hematopoietic transplantation using palifermin].
Pérez-Roca L; Sánchez-Ortega I; Duarte RF
Methods Find Exp Clin Pharmacol; 2010 Dec; 32 Suppl A():15-7. PubMed ID: 21381283
[TBL] [Abstract][Full Text] [Related]
7. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte and granulocyte-macrophage colony-stimulating factors in allografts: uses, misuses, misconceptions, and future applications.
Ringdén OT; Le Blanc K; Remberger M
Exp Hematol; 2005 May; 33(5):505-12. PubMed ID: 15850828
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic growth factors in bone marrow transplantation.
Mertelsmann R; Herrmann F; Hecht T; Schulz G
Bone Marrow Transplant; 1990 Aug; 6(2):73-7. PubMed ID: 1698494
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic growth factors in autologous bone marrow transplantation.
Miller AM
Semin Oncol; 1993 Oct; 20(5 Suppl 6):88-95. PubMed ID: 7692607
[TBL] [Abstract][Full Text] [Related]
11. Thymus and immune reconstitution after allogeneic hematopoietic stem cell transplantation in humans: never say never again.
Toubert A; Glauzy S; Douay C; Clave E
Tissue Antigens; 2012 Feb; 79(2):83-9. PubMed ID: 22220718
[TBL] [Abstract][Full Text] [Related]
12. The thymus in GVHD pathophysiology.
Krenger W; Holländer GA
Best Pract Res Clin Haematol; 2008 Jun; 21(2):119-28. PubMed ID: 18503980
[TBL] [Abstract][Full Text] [Related]
13. Optimal use of G-CSF administration after hematopoietic SCT.
Trivedi M; Martinez S; Corringham S; Medley K; Ball ED
Bone Marrow Transplant; 2009 Jun; 43(12):895-908. PubMed ID: 19363527
[TBL] [Abstract][Full Text] [Related]
14. Improving immune reconstitution while preventing GvHD in allogeneic stem cell transplantation.
André-Schmutz I; Dal Cortivo L; Fischer A; Cavazzana-Calvo M
Cytotherapy; 2005; 7(2):102-8. PubMed ID: 16040389
[TBL] [Abstract][Full Text] [Related]
15. Compromised recovery of natural interferon-alpha/beta-producing cells after allogeneic hematopoietic stem cell transplantation complicated by acute graft-versus-host disease and glucocorticoid administration.
Kitawaki T; Kadowaki N; Ishikawa T; Ichinohe T; Uchiyama T
Bone Marrow Transplant; 2003 Jul; 32(2):187-94. PubMed ID: 12838284
[TBL] [Abstract][Full Text] [Related]
16. Cytokines following SCT: indications and controversies.
Badell I;
Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S27-9. PubMed ID: 18545239
[TBL] [Abstract][Full Text] [Related]
17. Regulatory CD4+CD25hi T cells conserve their function and phenotype after granulocyte colony-stimulating factor treatment in human hematopoietic stem cell transplantation.
Noël G; Bruniquel D; DeGuibert S; Birebent B; Grosset JM; Bernard M; Dauriac C; Lamy-de-la-Chapelle T; Semana G; Brinster C
Hum Immunol; 2008 Jun; 69(6):329-37. PubMed ID: 18571003
[TBL] [Abstract][Full Text] [Related]
18. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
19. Growth factors in allogeneic transplantation.
Nemunaitis J
Semin Oncol; 1993 Oct; 20(5 Suppl 6):96-101. PubMed ID: 8211221
[TBL] [Abstract][Full Text] [Related]
20. Risk assessment in haematopoietic stem cell transplantation: stem cell source.
Urbano-Ispizua A
Best Pract Res Clin Haematol; 2007 Jun; 20(2):265-80. PubMed ID: 17448961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]